Ambrosia

Confirm your age

You must be over 18 to enter this website. Please enter your date of birth to continue.

By entering you confirm you are 18 or older and agree to our Terms and Privacy Policy.

Back to articles
Anti-inflammatoryKPVResearch

KPV for Gut and Skin Inflammation: What the Research Shows

Published by Ambrosia In-House Council2026-11-02 3 min read
Medically reviewed by Ambrosia clinical team

KPV is a three-amino-acid fragment of a natural hormone. Here's what laboratory and animal research suggests about inflammation, and why human evidence is still limited.

KPV for Gut and Skin Inflammation: What the Research Shows

A small fragment of a natural hormone

KPV is made of just three amino acids: lysine, proline and valine. It's the tail end of alpha-melanocyte-stimulating hormone (alpha-MSH), which your body produces and which has known anti-inflammatory activity.

Researchers have studied KPV to see whether this small fragment can reduce inflammation without the wider hormonal effects of alpha-MSH.

What the gut research found

The best-known study was published in Gastroenterology in 2008. It tested KPV in human intestinal cells and immune cells in the laboratory, and in two mouse models of colitis.

  • KPV entered cells through PepT1, a transporter that becomes more active in the inflamed colon.
  • In cells, very low concentrations reduced inflammatory signalling and the release of pro-inflammatory cytokines.
  • In mice, KPV added to drinking water reduced colitis and lowered markers of inflammation.

The authors suggested KPV might become a new treatment for inflammatory bowel disease. That remains a research hypothesis, because this study didn't test KPV in people.

How it may work

An earlier mouse study found that KPV reduced the build-up of inflammatory white blood cells. Its effect didn't appear to depend on the melanocortin receptors used by alpha-MSH, and the authors thought it more likely acted by inhibiting IL-1 beta, an inflammatory signal.

This distinction matters because the mechanism still isn't settled. Taken together, these studies show how KPV behaves in early research, not how well it treats a person's condition.

What about skin?

Interest in KPV for skin comes from the wider anti-inflammatory research on alpha-MSH and related fragments. We didn't find good-quality human trials showing that injected KPV improves inflammatory skin conditions, so any benefit is unproven.

What we don't know yet

  • Whether KPV works in people with inflammatory bowel disease or skin conditions
  • Whether an injection works as well as the oral route tested in mice
  • The best dose and treatment length
  • Long-term safety in humans

KPV doesn't replace your current treatment

Conditions such as Crohn's disease and ulcerative colitis need proper specialist care. Don't stop or reduce a prescribed medicine because you've started KPV. Blood in your stool, weight loss, fever or severe abdominal pain should be assessed by a doctor promptly.

Who should avoid it

Ambrosia's product information lists these reasons not to use KPV:

  • Active cancer
  • Pregnancy or breastfeeding
  • Known hypersensitivity to melanocortin fragments

Tell your doctor if you use immunosuppressants, biologics or other anti-inflammatory medicines. Possible side effects include injection-site redness or soreness, mild nausea and headache.

How it's prescribed

Ambrosia dispenses KPV as a 14 mg cartridge in 2,4 ml, usually injected once a day. Your doctor decides whether it suits you and sets your dose. Every Ambrosia treatment requires a prescription.

This article is for educational purposes only and is not medical advice.

References

Recommended for you

Shop the products mentioned in this article — complete your intake to order.

KPV Cartridge
Cold chain

KPV Cartridge

R 1360.00 Incl. VAT

TB-500 Cartridge
Cold chain

TB-500 Cartridge

R 1760.00 Incl. VAT

BPC-157 Cartridge
Cold chain

BPC-157 Cartridge

R 1368.00 Incl. VAT

Wolverine Stack Cartridge
Cold chain

Wolverine Stack Cartridge

R 2512.00 Incl. VAT